Clinical Trial Detail

NCT ID NCT03050554
Title Stereotactic Body Radiation Therapy (SBRT) Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Andrew Sharabi
Indications

lung non-small cell carcinoma

Therapies

Avelumab

Age Groups: adult senior

No variant requirements are available.